Quarterly Report

Spyre Therapeutics, Inc. Filed 2024-05-09 Acc 0001636282-24-000037

Documents 1

2024-08-07 10-Q Quarterly Report
2024-05-16 4 Changes in Ownership
2024-05-15 424B3 Prospectus
2024-05-15 8-K Material agreement · Executive or director change · Bylaws or fiscal year change · Shareholder vote results · Regulation FD disclosure
2024-05-09 8-K Results of operations
2024-05-09 10-Q Quarterly Report
2023-11-09 10-Q Quarterly Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading syre-20240331.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…